Congenital muscular dystrophies: New aspects of an expanding group of disorders

Matthew T. Lisi, Ronald D. Cohn

Research output: Contribution to journalArticle

Abstract

The congenital muscular dystrophies comprise a genetically and clinically heterogeneous group of disorders characterized by early onset of progressive muscle weakness and often involvement of other organ systems such as the brain and eyes. During the last decade, significant progress has been made to further characterize various forms of congenital muscular dystrophies based on their specific genetic and clinical appearance. This review represents an overview of the recent accomplishments as they relate to clinical, diagnostic, pathogenetic and therapeutic aspects of congenital muscular dystrophies.

Original languageEnglish (US)
Pages (from-to)159-172
Number of pages14
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1772
Issue number2
DOIs
StatePublished - Feb 2007

Fingerprint

Muscular Dystrophies
Muscle Weakness
Brain
Therapeutics

Keywords

  • Dystroglycan
  • Integrins
  • Laminin-α2
  • Muscular dystrophy
  • Selenoprotein N

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Biophysics

Cite this

Congenital muscular dystrophies : New aspects of an expanding group of disorders. / Lisi, Matthew T.; Cohn, Ronald D.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1772, No. 2, 02.2007, p. 159-172.

Research output: Contribution to journalArticle

@article{c970cbcffa454e6abddc98b3be656c66,
title = "Congenital muscular dystrophies: New aspects of an expanding group of disorders",
abstract = "The congenital muscular dystrophies comprise a genetically and clinically heterogeneous group of disorders characterized by early onset of progressive muscle weakness and often involvement of other organ systems such as the brain and eyes. During the last decade, significant progress has been made to further characterize various forms of congenital muscular dystrophies based on their specific genetic and clinical appearance. This review represents an overview of the recent accomplishments as they relate to clinical, diagnostic, pathogenetic and therapeutic aspects of congenital muscular dystrophies.",
keywords = "Dystroglycan, Integrins, Laminin-α2, Muscular dystrophy, Selenoprotein N",
author = "Lisi, {Matthew T.} and Cohn, {Ronald D.}",
year = "2007",
month = "2",
doi = "10.1016/j.bbadis.2006.09.006",
language = "English (US)",
volume = "1772",
pages = "159--172",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Congenital muscular dystrophies

T2 - New aspects of an expanding group of disorders

AU - Lisi, Matthew T.

AU - Cohn, Ronald D.

PY - 2007/2

Y1 - 2007/2

N2 - The congenital muscular dystrophies comprise a genetically and clinically heterogeneous group of disorders characterized by early onset of progressive muscle weakness and often involvement of other organ systems such as the brain and eyes. During the last decade, significant progress has been made to further characterize various forms of congenital muscular dystrophies based on their specific genetic and clinical appearance. This review represents an overview of the recent accomplishments as they relate to clinical, diagnostic, pathogenetic and therapeutic aspects of congenital muscular dystrophies.

AB - The congenital muscular dystrophies comprise a genetically and clinically heterogeneous group of disorders characterized by early onset of progressive muscle weakness and often involvement of other organ systems such as the brain and eyes. During the last decade, significant progress has been made to further characterize various forms of congenital muscular dystrophies based on their specific genetic and clinical appearance. This review represents an overview of the recent accomplishments as they relate to clinical, diagnostic, pathogenetic and therapeutic aspects of congenital muscular dystrophies.

KW - Dystroglycan

KW - Integrins

KW - Laminin-α2

KW - Muscular dystrophy

KW - Selenoprotein N

UR - http://www.scopus.com/inward/record.url?scp=33846265912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846265912&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2006.09.006

DO - 10.1016/j.bbadis.2006.09.006

M3 - Article

C2 - 17097859

AN - SCOPUS:33846265912

VL - 1772

SP - 159

EP - 172

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 2

ER -